ID   MYO5A_RAT               Reviewed;        1828 AA.
AC   Q9QYF3;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=Unconventional myosin-Va;
DE   AltName: Full=Dilute myosin heavy chain, non-muscle;
GN   Name=Myo5a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10920234; DOI=10.1007/s003350010121;
RA   Futaki S., Takagishi Y., Hayashi Y., Ohmori S., Kanou Y., Inouye M.,
RA   Oda S., Seo H., Iwaikawa Y., Murata Y.;
RT   "Identification of a novel myosin-Va mutation in an ataxic mutant rat,
RT   dilute-opisthotonus.";
RL   Mamm. Genome 11:649-655(2000).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1032, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH RIPL2.
RX   PubMed=19812310; DOI=10.1242/jcs.050344;
RA   Lise M.F., Srivastava D.P., Arstikaitis P., Lett R.L., Sheta R.,
RA   Viswanathan V., Penzes P., O'Connor T.P., El-Husseini A.;
RT   "Myosin-Va-interacting protein, RILPL2, controls cell shape and neuronal
RT   morphogenesis via Rac signaling.";
RL   J. Cell Sci. 122:3810-3821(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-600; SER-1425 AND SER-1625,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Processive actin-based motor that can move in large steps
CC       approximating the 36-nm pseudo-repeat of the actin filament. Involved
CC       in melanosome transport. Also mediates the transport of vesicles to the
CC       plasma membrane. May also be required for some polarization process
CC       involved in dendrite formation. {ECO:0000269|PubMed:19812310}.
CC   -!- SUBUNIT: May be a homodimer, which associates with multiple calmodulin
CC       or myosin light chains (By similarity). Interacts with RIPL2, the
CC       interaction is required for its role in dendrite formation
CC       (PubMed:19812310). Interacts with MLPH. Interacts with SYTL4 (By
CC       similarity). Interacts with MYRIP (By similarity). Interacts with
CC       RAB10; mediates the transport to the plasma membrane of SLC2A4/GLUT4
CC       storage vesicles (By similarity). Interacts with FMR1; this interaction
CC       occurs in association with polyribosome (By similarity).
CC       {ECO:0000250|UniProtKB:Q99104, ECO:0000269|PubMed:19812310}.
CC   -!- DISEASE: Note=Defects in Myo5a are a cause of Dilute-opisthotonus
CC       (dop). Dop rats have diluted coat color and are occasionally associated
CC       with severe neurological disorders.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB035736; BAA88350.1; -; mRNA.
DR   RefSeq; NP_071514.1; NM_022178.1.
DR   AlphaFoldDB; Q9QYF3; -.
DR   SMR; Q9QYF3; -.
DR   BioGRID; 247098; 8.
DR   IntAct; Q9QYF3; 3.
DR   MINT; Q9QYF3; -.
DR   STRING; 10116.ENSRNOP00000073223; -.
DR   GlyGen; Q9QYF3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9QYF3; -.
DR   PhosphoSitePlus; Q9QYF3; -.
DR   jPOST; Q9QYF3; -.
DR   GeneID; 25017; -.
DR   KEGG; rno:25017; -.
DR   UCSC; RGD:3143; rat.
DR   AGR; RGD:3143; -.
DR   CTD; 4644; -.
DR   RGD; 3143; Myo5a.
DR   InParanoid; Q9QYF3; -.
DR   OrthoDB; 1094820at2759; -.
DR   PhylomeDB; Q9QYF3; -.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-9824585; Regulation of MITF-M-dependent genes involved in pigmentation.
DR   PRO; PR:Q9QYF3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015629; C:actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005884; C:actin filament; ISO:RGD.
DR   GO; GO:0042641; C:actomyosin; ISO:RGD.
DR   GO; GO:0042642; C:actomyosin, myosin complex part; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0032433; C:filopodium tip; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0032593; C:insulin-responsive compartment; ISS:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; ISO:RGD.
DR   GO; GO:0005764; C:lysosome; ISO:RGD.
DR   GO; GO:0042470; C:melanosome; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0016459; C:myosin complex; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005777; C:peroxisome; ISO:RGD.
DR   GO; GO:0001750; C:photoreceptor outer segment; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098871; C:postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0055037; C:recycling endosome; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:RGD.
DR   GO; GO:0001726; C:ruffle; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0016461; C:unconventional myosin complex; ISO:RGD.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IPI:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0003774; F:cytoskeletal motor activity; IMP:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0000149; F:SNARE binding; IPI:RGD.
DR   GO; GO:0017075; F:syntaxin-1 binding; IPI:RGD.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0030048; P:actin filament-based movement; IDA:RGD.
DR   GO; GO:0099640; P:axo-dendritic protein transport; IMP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0048066; P:developmental pigmentation; ISO:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; IMP:RGD.
DR   GO; GO:0051643; P:endoplasmic reticulum localization; ISO:RGD.
DR   GO; GO:0099089; P:establishment of endoplasmic reticulum localization to postsynapse; ISO:RGD.
DR   GO; GO:0006887; P:exocytosis; ISO:RGD.
DR   GO; GO:0048820; P:hair follicle maturation; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; ISO:RGD.
DR   GO; GO:0042759; P:long-chain fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0016236; P:macroautophagy; IMP:RGD.
DR   GO; GO:0042438; P:melanin biosynthetic process; ISO:RGD.
DR   GO; GO:0006582; P:melanin metabolic process; ISO:RGD.
DR   GO; GO:0030318; P:melanocyte differentiation; ISO:RGD.
DR   GO; GO:0032400; P:melanosome localization; ISO:RGD.
DR   GO; GO:0032402; P:melanosome transport; ISO:RGD.
DR   GO; GO:0042552; P:myelination; ISO:RGD.
DR   GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD.
DR   GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0042476; P:odontogenesis; ISO:RGD.
DR   GO; GO:0043473; P:pigmentation; IMP:MGI.
DR   GO; GO:1900078; P:positive regulation of cellular response to insulin stimulus; IMP:RGD.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IMP:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IMP:RGD.
DR   GO; GO:0150103; P:reactive gliosis; IMP:RGD.
DR   GO; GO:0017157; P:regulation of exocytosis; IMP:RGD.
DR   GO; GO:0099566; P:regulation of postsynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0032252; P:secretory granule localization; IDA:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0030050; P:vesicle transport along actin filament; IMP:RGD.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; ISO:RGD.
DR   CDD; cd15478; Myo5a_CBD; 1.
DR   CDD; cd01380; MYSc_Myo5; 1.
DR   Gene3D; 1.10.10.820; -; 1.
DR   Gene3D; 1.20.5.190; -; 3.
DR   Gene3D; 1.20.58.530; -; 1.
DR   Gene3D; 3.30.70.1590; -; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1.
DR   InterPro; IPR002710; Dilute_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR037988; Myo5a_CBD.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR036103; MYSc_Myo5.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR13140; MYOSIN; 1.
DR   PANTHER; PTHR13140:SF273; UNCONVENTIONAL MYOSIN-VA; 1.
DR   Pfam; PF01843; DIL; 1.
DR   Pfam; PF00612; IQ; 6.
DR   Pfam; PF00063; Myosin_head; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM01132; DIL; 1.
DR   SMART; SM00015; IQ; 6.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 3.
DR   PROSITE; PS51126; DILUTE; 1.
DR   PROSITE; PS50096; IQ; 6.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; ATP-binding; Calmodulin-binding; Coiled coil;
KW   Motor protein; Myosin; Nucleotide-binding; Phosphoprotein;
KW   Protein transport; Reference proteome; Repeat; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4I1"
FT   CHAIN           2..1828
FT                   /note="Unconventional myosin-Va"
FT                   /id="PRO_0000123458"
FT   DOMAIN          8..60
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          69..763
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          766..788
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          789..813
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          814..836
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          837..861
FT                   /note="IQ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          862..884
FT                   /note="IQ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          885..914
FT                   /note="IQ 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1507..1783
FT                   /note="Dilute"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00503"
FT   REGION          599..633
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          643..665
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          1105..1147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          914..1239
FT                   /evidence="ECO:0000255"
FT   COILED          1314..1418
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        599..613
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         163..170
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y4I1"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1032
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         1425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1625
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1733
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1828 AA;  211764 MW;  5B3DE1C89AE36123 CRC64;
     MAASELYTKF ARVWIPDPEE VWKSAELLKD YKPGDKVLLL HLEEGKDLEY RLDPKTSELP
     HLRNPDILVG ENDLTALSYL HEPAVLHNLR VRFIDSKLIY TYCGIVLVAI NPYEQLPIYG
     EDIINAYSGQ NMGDMDPHIF AVAEEAYKQM ARDERNQSII VSGESGAGKT VSAKYAMRYF
     ATVSGSASEA NVEEKVLASN PIMESIGNAK TTRNDNSSRF GKYIEIGFDK RYRIIGANMR
     TYLLEKSRVV FQAEEERNYH IFYQLCASAK LPEFKMLRLG NADSFHYTKQ GGSPMIEGVD
     DAKEMAHTRQ ACTLLGISES YQMGIFRILA GILHLGNVGF ASRDSDSCTI PPKHEPLIIF
     CDLMGVDYEE MCHWLCHRKL ATATETYIKP ISKLQATNAR DALAKHIYAK LFNWIVGHVN
     QALHSAVKQH SFIGVLDIYG FETFEINSFE QFCINYANEK LQQQFNMHVF KLEQEEYMKE
     QIPWTLIDFY DNQPCINLIE SKLGILDLLD EECKMPKGTD DTWAQKLYNT HLNKCALFEK
     PRMSNKAFII KHFADKVEYQ CEGFLEKNKD TVFEEQIKVL KSSKFKMLPE LFQDDEKAIS
     PTSATSSGRT PLTRVPVKPT KGRPGQTAKE HKKTVGLQFR NSLHLLMETL NATTPHYVRC
     IKPNDFKFPF TFDEKRAVQQ LRACGVLETI RISAAGFPSR WTYQEFFSRY RVLMKQKDVL
     GDRKQTCQNV LEKLILDKDK YQFGKTKIFF RAGQVAYLEK LRADKLRAAC IRIQKTIRGW
     LLRKRYLCMQ RAAITVQRYV RGYQARCYAK FLRRTKAATT IQKYWRMYVV RRKYKIRRAA
     TIVLQSYLRG YLARNRYRKI LREHKAVIIQ KRVRGWLART HYKRTMKAII YLQCCFRRMM
     AKRELKKLKI EARSVERYKK LHIGMENKIM QLQRKVDEQN KDYKCLMEKL TNLEGVYNSE
     TEKLRNDVER LQLSEEEAKV ATGRVLSLQE EIAKLRKDLE QTRSEKKSIE ERADKYKQET
     EQLVSNLKEE NTLLKQEKET LNHLMVEQAK EMTETMERKL VEETKQLELD LNDERLRYQN
     LLNEFSRLEE RYDDLKEEMT LMLNVPKPGH KRTDSTHSSN ESEYTFSSEF AETEDIAPRT
     EEPTEKKVPL DMSLFLKLQK RVTELGQEKQ LMQDELDRKE EQVLRSKAKG GERPQIRGAE
     LGYESLKRQE LESENKKLKN ELNELRKALS EKSAPEVNAP GAPAYRVLME QLTAVSEELD
     VRKEEVLILR SQLVSQKEAI QPKDDKNTMT DSTILLEDVQ KMKDKGEIAQ AYIGLKETNR
     LLESQLQSQK RSHENEAEAL RGEIQSLKEE NNRQQQLLAQ NLQLPPEARI EASLQHEITR
     LTNENLDLME QLEKQDKTVR KLKKQLKVFA KKIGELEVGQ MENISPGQII DEPIRPVNIP
     RKGKDFQGML EYKREDEQKL VKNLILELKP RGVAVNLISG LPAYILFMCV RHADYLDDDQ
     KVRSLLTSTI NSIKKVLKKR GDDFETVSFW LSNTCRFLHC LKQYSGEEGF MKHNTSRQNE
     HCLTNFDLAE YRQVLSDLAI QIYQQLVRVL ENILQPMIVS GMLEHETIQG VSGVKPTGLR
     KRTSSIADEG TYTLDSILRQ LNSFHSVMCQ HGMDPELIKQ VVKQMFYIVG AITLNNLLLR
     KDMCSWSKGM QIRYNVSQLE EWLRDKNLMN SGAKETLEPL IQAAQLLQVK KKTDDDAEAI
     CSMCNALTTA QIVKVLNLYT PVNEFEERVS VSFIRTIQVR LRDRKDSPQL LMDAKHIFPV
     TFPFNPSSLA LETIQIPASL GLGFIARV
//
